3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
6
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Breast Cancer
2
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Anxiety Disorders
1
Amyotrophic Lateral Sclerosis
1
Interventions
Gemcitabine
5
Cisplatin
5
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Fluorouracil
4
durvalumab
3
Taxes
3
futibatinib
2
fludarabine
2
Specimen Handling
2
Platinum
2
Paclitaxel
2
Nivolumab
2
Irinotecan
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
ulixertinib
1
tocilizumab
1
tivozanib
1
tislelizumab
1
regorafenib
1
pevonedistat
1
pemigatinib
1
pembrolizumab
1
olutasidenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Injections
×
30 days
×
Clear all
No trials found.